Nattokinase Research Guide

Full name: Nattokinase (Subtilisin NAT)

A fibrinolytic enzyme extracted from natto (fermented soybeans) with potent clot-dissolving properties. Used for cardiovascular protection, blood pressure reduction, and as a natural alternative to pharmaceutical anticoagulants.

How Nattokinase Works

Directly degrades fibrin in blood clots via proteolytic activity. Also activates endogenous tissue plasminogen activator (tPA) and suppresses plasminogen activator inhibitor-1 (PAI-1), enhancing the body's own fibrinolytic system.

Dosing Protocol

• Typical dose: 2000-4000 FU (fibrinolytic units)
• Frequency: Daily on empty stomach
• Duration: Ongoing
• Route: Oral capsule

Reported Benefits

• Fibrin clot dissolution
• Blood pressure reduction
• Improved blood viscosity
• Reduced DVT risk
• Atherosclerosis prevention
• Natural anticoagulant alternative

Potential Side Effects

• Increased bleeding risk
• Bruising
• Rare: GI discomfort
• Contraindicated pre-surgery

Research Citations

1. Nattokinase and blood pressure (2021) - Meta-analysis of 12 RCTs showed systolic BP reduction of 5.5 mmHg and diastolic 2.7 mmHg over 8 weeks of supplementation.
2. Nattokinase fibrinolytic activity in humans (2022) - 4000 FU/day reduced D-dimer and fibrin degradation products by 35% in healthy adults with elevated cardiovascular risk.

Related Cardiovascular Compounds

• Serrapeptase - Full Profile
• CoQ10 - Full Profile
• Omega-3 (EPA/DHA) - Full Profile
• Bergamot Extract - Full Profile
• Telmisartan - Full Profile
• Vesugen - Full Profile

View full Nattokinase profile with 3D molecule viewer →